Pfizer wins $10B obesity drug takeover battle
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Exclusive analysis reveals America's alarming dependence on foreign nations for essential minerals including copper, uranium, and potash. Discover how this vulnerability impacts everything from energy security to food production and what strategic moves a
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Quebec's vaccination campaign struggles with massive appointment backlogs as persistent supply shortages leave thousands waiting. Health officials scramble for solutions while public frustration grows.
Vancouver's beloved Herschel Supply Co. teams up with Heinz in a surprising fashion collaboration featuring ketchup-inspired accessories. Discover the limited-edition collection blending street style with iconic condiment branding.
Groundbreaking DP World research exposes how geopolitical instability threatens global supply chains, with 96% of executives reporting significant disruptions in past year.
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Albertans seeking COVID-19 vaccinations are encountering significant delays as pharmacies across the province grapple with supply chain issues and overwhelming demand.
Beijing escalates semiconductor trade tensions, blaming Dutch government for blocking Chinese investment in chipmaker Nexperia and threatening global supply chains.
New Descartes research reveals freight forwarders and customs brokers are betting big on technology to drive business expansion and overcome industry challenges.
Albertans seeking COVID-19 vaccinations are encountering significant wait times at pharmacies across the province as limited vaccine supply struggles to meet overwhelming public demand.
Canada's NDP considers abstaining from federal budget vote, putting Justin Trudeau's government in precarious position despite supply-and-confidence agreement.
Critical shortages of hydromorphone and other essential pain medications continue to plague Canadian pharmacies, leaving patients scrambling as supply chain issues persist.
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Fear of tenant lobby groups is preventing Ontario from implementing crucial rental reforms that could boost housing supply and affordability across the province.
Canada is spearheading high-stakes G7 negotiations to create a strategic critical minerals partnership, responding to recent diplomatic warming between the United States and China that could reshape global supply chains.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Global trade leader DP World successfully transports 400 tons of fresh Peruvian blueberries to American consumers, showcasing efficient cold chain logistics and expanding North American fruit availability.
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
A former Melita pharmacy manager faces consequences after being convicted of multiple professional misconduct charges, including improper prescription practices and record-keeping failures.
Canada is spearheading a groundbreaking G7 critical minerals partnership to secure supply chains and reduce reliance on China for essential green technology components.
A groundbreaking economic study shows Windsor's strategic port expansion could unlock massive economic benefits and create new international trade opportunities for Canadian businesses.